Posizioni attive di David S. Johnson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
GigaGen, Inc.
 GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/01/2010 | - | |
| Fondatore | 01/01/2010 | - | |
| Presidente | 01/01/2010 | - | |
GigaMune, Inc.
 GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Amministratore Delegato | - | - |
| Direttore Finanziario/CFO | - | - | |
| Segretario Aziendale | - | - |
Storia della carriera di David S. Johnson
Precedenti posizioni note di David S. Johnson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NATERA, INC. | Direttore operativo | - | - |
| Stanford University | Corporate Officer/Principal | - | - |
Formazione di David S. Johnson
| Stanford University | Doctorate Degree |
| Duke University | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Health Technology |
GigaMune, Inc.
GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Health Technology |
- Borsa valori
- Insiders
- David S. Johnson
- Esperienza
